• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 305U225
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Atrial Fibrillation (1729); Atrial Tachycardia (1731); Bradycardia (1751); Cardiac Arrest (1762); Dyspnea (1816); Dizziness (2194); Complete Heart Block (2627)
Event Date 10/22/2014
Event Type  Injury  
Event Description
Medtronic received information that the day after implant of this bioprosthetic aortic heart valve, the patient exhibited dizziness and dyspnea due to transient third-degree heart block with pauses and sinus bradycardia.Temporary pacing support was provided.Three days post-implant, the patient exhibited atrial fibrillation, and was treated with medication which resulted in conversion to a sinus rhythm.Six days post-implant, the patient was symptomatic with observations of 2:1 atrio-ventricular heart block with bradycardia and complete heart block.A permanent pacemaker was implanted the following day.The patient then exhibited atrial tachycardia with ventricular response, which was successfully treated with medication.No subsequent adverse patient effects were reported.
 
Manufacturer Narrative
The product remains implanted and therefore has not been returned to medtronic.(b)(4).
 
Manufacturer Narrative
Conduction disturbances such as (i.E.Atrial fibrillation, bradycardia and heart block) are known potential adverse effects and can be resolved with medical treatment or the implant of a permanent pacemaker.A conduction disturbance does not indicate a device malfunction or potential manufacturing issue.The device remains implanted.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e. deere ave.
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key4242968
MDR Text Key5018260
Report Number2025587-2014-00876
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,health professional,stu
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/12/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/14/2019
Device Model Number305U225
Device Catalogue Number305U225
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/12/2014
Initial Date FDA Received11/11/2014
Supplement Dates Manufacturer ReceivedNot provided
12/12/2014
Supplement Dates FDA Received01/03/2015
09/15/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured06/10/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00079 YR
-
-